Search research articles
Contact Us
Filters
Showing results (11-20 of 109) with videos related to
Page
of 11
Sort By:
International Journal of Radiation Oncology, Biology, Physics
|
August 4, 2012
Enteral feeding tubes in patients undergoing definitive chemoradiation therapy for head-and-neck cancer: a critical review
Shlomo A Koyfman, David J Adelstein
Cancer
|
August 10, 2016
Use of systemic therapy with definitive radiotherapy for elderly patients with head and neck cancer: A National Cancer Data Base analysis
Matthew C Ward, Chandana A Reddy, David J Adelstein, et al.
Seminars in Radiation Oncology
|
June 13, 2012
Biology and management of salivary gland cancers
David J Adelstein, Shlomo A Koyfman, Adel K El-Naggar, et al.
Investigational New Drugs
|
August 25, 2011
A phase II trial of gefitinib for recurrent or metastatic cancer of the esophagus or gastroesophageal junction
David J Adelstein, Cristina P Rodriguez, Lisa A Rybicki, et al.
Investigational New Drugs
|
April 5, 2013
A Phase I study of the combination of oxaliplatin/docetaxel and vandetanib for the treatment of advanced gastroesophageal cancer
Balazs Halmos, Yuxia Jia, Joseph A Bokar, et al.
Cancer
|
January 10, 2018
Increased pathologic upstaging with rising time to treatment initiation for head and neck cancer: A mechanism for increased mortality
Roy Xiao, Matthew C Ward, Kailin Yang, et al.
American Journal of Otolaryngology
|
December 18, 2009
Impact of preepiglottic space tumor involvement on concurrent chemoradiation therapy
Walter T Lee, Mark Rizzi, Joseph Scharpf, et al.
Head & Neck
|
August 31, 2019
The prognostic impact of level I lymph node involvement in oropharyngeal squamous cell carcinoma
Roy Xiao, Matthew C Ward, Kailin Yang, et al.
American Journal of Otolaryngology
|
June 24, 2011
Intended single-modality management of T1 and T2 tonsillar carcinomas: retrospective comparison of radical tonsillectomy vs radiation from a single institution
Eric D Lamarre, Rahul Seth, Robert R Lorenz, et al.
Head & Neck
|
June 27, 2009
Docetaxel, cisplatin, and fluorouracil induction chemotherapy followed by accelerated fractionation/concomitant boost radiation and concurrent cisplatin in patients with advanced squamous cell head and neck cancer: A Southwest Oncology Group phase II trial (S0216)
David J Adelstein, James Moon, Ehab Hanna, et al.
Page
of 11
Search research articles
Search
Showing results (11-20 of 109) with videos related to
Sort By:
Page
of 11
International Journal of Radiation Oncology, Biology, Physics
|
August 4, 2012
Enteral feeding tubes in patients undergoing definitive chemoradiation therapy for head-and-neck cancer: a critical review
Shlomo A Koyfman, David J Adelstein
Cancer
|
August 10, 2016
Use of systemic therapy with definitive radiotherapy for elderly patients with head and neck cancer: A National Cancer Data Base analysis
Matthew C Ward, Chandana A Reddy, David J Adelstein, et al.
Seminars in Radiation Oncology
|
June 13, 2012
Biology and management of salivary gland cancers
David J Adelstein, Shlomo A Koyfman, Adel K El-Naggar, et al.
Investigational New Drugs
|
August 25, 2011
A phase II trial of gefitinib for recurrent or metastatic cancer of the esophagus or gastroesophageal junction
David J Adelstein, Cristina P Rodriguez, Lisa A Rybicki, et al.
Investigational New Drugs
|
April 5, 2013
A Phase I study of the combination of oxaliplatin/docetaxel and vandetanib for the treatment of advanced gastroesophageal cancer
Balazs Halmos, Yuxia Jia, Joseph A Bokar, et al.
Cancer
|
January 10, 2018
Increased pathologic upstaging with rising time to treatment initiation for head and neck cancer: A mechanism for increased mortality
Roy Xiao, Matthew C Ward, Kailin Yang, et al.
American Journal of Otolaryngology
|
December 18, 2009
Impact of preepiglottic space tumor involvement on concurrent chemoradiation therapy
Walter T Lee, Mark Rizzi, Joseph Scharpf, et al.
Head & Neck
|
August 31, 2019
The prognostic impact of level I lymph node involvement in oropharyngeal squamous cell carcinoma
Roy Xiao, Matthew C Ward, Kailin Yang, et al.
American Journal of Otolaryngology
|
June 24, 2011
Intended single-modality management of T1 and T2 tonsillar carcinomas: retrospective comparison of radical tonsillectomy vs radiation from a single institution
Eric D Lamarre, Rahul Seth, Robert R Lorenz, et al.
Head & Neck
|
June 27, 2009
Docetaxel, cisplatin, and fluorouracil induction chemotherapy followed by accelerated fractionation/concomitant boost radiation and concurrent cisplatin in patients with advanced squamous cell head and neck cancer: A Southwest Oncology Group phase II trial (S0216)
David J Adelstein, James Moon, Ehab Hanna, et al.
Page
of 11